Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor

Pyoderma gangrenosum manifests as an ulceration of the skin often associated with several systemic diseases. The diagnosis is usually made by exclusion criteria with suggestions made by clinical findings and histological features. It can occur any site but more common in the legs. Advances in transl...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheinberg, Morton, Machado, Luis Antônio, M Castro, Luiz Guilherme, Ferreira, Sineida Berbert, Michalany, Nilceo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100614/
https://www.ncbi.nlm.nih.gov/pubmed/33997753
http://dx.doi.org/10.1016/j.jtauto.2021.100099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100614/
https://www.ncbi.nlm.nih.gov/pubmed/33997753
http://dx.doi.org/10.1016/j.jtauto.2021.100099

Ejemplares similares